JP Morgan Chase
STIM icon

JP Morgan Chase’s Neuronetics STIM Stock Holding History

JP Morgan Chase’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,800
Closed -$4.91K – 7759
2025
Q3 		$4.91K Buy
+1,800
New +$6.39K ﹤0.01% 6782

Other funds holding STIM

MAM
Madryn Asset Management New York $34.1M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase's STIM Position: Q1 2026 in Review

JP Morgan Chase increased its Neuronetics (STIM) stake by 29% in Q1 2026, buying an estimated $7.69K and bringing the position to 21,429 shares worth $27.2K. The position accounts for ﹤0.01% of the portfolio, ranked #6437.

JP Morgan Chase first reported a position in STIM in Q3 2018 and has held it in 31 quarters since. The position peaked at $1.5M in Q1 2019. 99 funds tracked by Wall St. Rank hold STIM as of Q1 2026.

  • JP Morgan Chase held 21,429 shares of Neuronetics worth $27.2K as of Q1 2026.
  • JP Morgan Chase bought 4,853 Neuronetics shares in Q1 2026, an estimated $7.69K.
  • Neuronetics made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6437 holding.
  • JP Morgan Chase first reported a position in Neuronetics in Q3 2018 and has held it in 31 quarters since.
  • JP Morgan Chase's Neuronetics position peaked at $1.5M in Q1 2019.
  • 99 funds tracked by Wall St. Rank held Neuronetics as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.